Back
Arvinas, Inc. ARVN · Insights
Arvinas, Inc. is a biopharmaceutical company in the clinical development stage, dedicated to identif... Price6.76
Market Cap442.68 M
Float64.26 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro